These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 27766365)

  • 1. Current limitations and future opportunities for prediction of DILI from in vitro.
    Funk C; Roth A
    Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
    Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
    Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity evaluation using cryopreserved primary human hepatocytes in various culture formats.
    Richert L; Baze A; Parmentier C; Gerets HHJ; Sison-Young R; Dorau M; Lovatt C; Czich A; Goldring C; Park BK; Juhila S; Foster AJ; Williams DP
    Toxicol Lett; 2016 Sep; 258():207-215. PubMed ID: 27363785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
    Gómez-Lechón MJ; Tolosa L; Donato MT
    J Appl Toxicol; 2016 Jun; 36(6):752-68. PubMed ID: 26691983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies.
    Ezendam J; Braakhuis HM; Vandebriel RJ
    Arch Toxicol; 2016 Dec; 90(12):2861-2883. PubMed ID: 27629427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans.
    Atienzar FA; Novik EI; Gerets HH; Parekh A; Delatour C; Cardenas A; MacDonald J; Yarmush ML; Dhalluin S
    Toxicol Appl Pharmacol; 2014 Feb; 275(1):44-61. PubMed ID: 24333257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
    Ware BR; Berger DR; Khetani SR
    Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.
    Kostadinova R; Boess F; Applegate D; Suter L; Weiser T; Singer T; Naughton B; Roth A
    Toxicol Appl Pharmacol; 2013 Apr; 268(1):1-16. PubMed ID: 23352505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network.
    Segovia-Zafra A; Villanueva-Paz M; Serras AS; Matilla-Cabello G; Bodoque-García A; Di Zeo-Sánchez DE; Niu H; Álvarez-Álvarez I; Sanz-Villanueva L; Godec S; Milisav I; Bagnaninchi P; Andrade RJ; Lucena MI; Fernández-Checa JC; Cubero FJ; Miranda JP; Nelson LJ
    J Hepatol; 2024 Oct; 81(4):630-640. PubMed ID: 38703829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro.
    Jiang J; Pieterman CD; Ertaylan G; Peeters RLM; de Kok TMCM
    Arch Toxicol; 2019 Nov; 93(11):3067-3098. PubMed ID: 31586243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.
    Kawaguchi M; Nukaga T; Sekine S; Takemura A; Susukida T; Oeda S; Kodama A; Hirota M; Kouzuki H; Ito K
    Toxicol Appl Pharmacol; 2020 May; 394():114958. PubMed ID: 32198022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury.
    Lin C; Khetani SR
    Biomed Res Int; 2016; 2016():1829148. PubMed ID: 27725933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions.
    Vorrink SU; Zhou Y; Ingelman-Sundberg M; Lauschke VM
    Toxicol Sci; 2018 Jun; 163(2):655-665. PubMed ID: 29590495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and Functional Characterization and Assessment of iPSC-Derived Hepatocytes for In Vitro Toxicity Testing.
    Lu J; Einhorn S; Venkatarangan L; Miller M; Mann DA; Watkins PB; LeCluyse E
    Toxicol Sci; 2015 Sep; 147(1):39-54. PubMed ID: 26092927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel tools for the in vitro investigation of drug-induced liver injury.
    Jiang J; Wolters JE; van Breda SG; Kleinjans JC; de Kok TM
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1523-37. PubMed ID: 26155718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-enduring primary hepatocyte-based co-cultures improve prediction of hepatotoxicity.
    Novik EI; Dwyer J; Morelli JK; Parekh A; Cho C; Pludwinski E; Shrirao A; Freedman RM; MacDonald JS; Jayyosi Z
    Toxicol Appl Pharmacol; 2017 Dec; 336():20-30. PubMed ID: 28942002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans.
    Atienzar FA; Blomme EA; Chen M; Hewitt P; Kenna JG; Labbe G; Moulin F; Pognan F; Roth AB; Suter-Dick L; Ukairo O; Weaver RJ; Will Y; Dambach DM
    Biomed Res Int; 2016; 2016():9737920. PubMed ID: 27689095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles.
    Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W
    Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.